An intriguing case report has just been published of a 66 year old woman with metastatic melanoma who was treated with high dose mistletoe therapy.1 After two years she was in complete remission. Her cancer was confirmed with biopsy. She was treated with high dose intravenous mistletoe extract after declining chemotherapy. Doses of up to 2200mg of Iscador were used. Note that this is about one hundred times higher than “conventionally” dosed Iscador therapy. The patient also received a total of 26 intratumoral injections.
Here is a link to her before and after PET scans
The following is an excerpt from the patient’s description of her experience:
“I realized that my own commitment to becoming healthy was needed, and learned to be grateful for everything that was healthy in me. This commitment to my own health also involved the development of an awareness of my life, including uncovering all those things which were sabotaging me from the inside.”
The idea that an individual can impact their own care and health has been almost completely lost in the field of oncology.
This case report is compelling because it shows a patient who responded in a time related and dose related fashion to the intervention (mistletoe). Cases where patients use only one intervention are important as they exclude the possibility that actually some other treatment was the cause of tumor response.
The physician involved in this case has published other such case reports using mistletoe.
Addendum
The authors of this study, being the excellent scientists they are, wanted to add the following commentary: